bacteri
envelop
multilay
organel
surround
cell
provid
morpholog
structur
protect
environment
stressor
gramneg
organ
envelop
compris
inner
membran
im
outer
membran
om
periplasm
space
contain
peptidoglycan
cell
walla
highli
crosslink
meshlik
macromolecul
confer
mechan
strength
cell
figur
gramposit
bacteria
contrast
lack
om
thicker
surfaceexpos
cell
wall
figur
structur
studi
intens
year
bacteri
cell
biologist
antibiot
develop
among
other
due
critic
role
bacteri
growth
surviv
understand
bacteri
envelop
grown
howev
util
possess
power
set
techniqu
express
protein
cell
surfac
transform
envelop
target
basic
pharmaceut
research
versatil
platform
biotechnolog
innov
sinc
first
exampl
protein
display
bacteria
matur
robust
streamlin
methodolog
expans
rang
applic
includ
environment
remedi
biofuel
product
biocatalysi
biosens
protein
librari
screen
cancer
therapi
vaccinolog
recent
bacteri
surfac
engin
extend
beyond
polypeptid
paradigm
includ
sugar
well
technolog
refer
glycoengin
involv
heterolog
express
gene
mediat
saccharid
biosynthesi
enabl
display
varieti
nonn
proteoglycan
glycolipid
polysaccharid
surfac
recombin
bacteria
glycoengin
organ
turn
util
whole
cell
vaccin
antiinfect
probiot
live
factori
glycoconjug
synthesi
chapter
describ
repertoir
techniqu
establish
display
heterolog
protein
sugar
surfac
bacteria
discuss
reengin
bacteria
exploit
basic
appli
biolog
thu
far
throughout
attempt
highlight
recent
develop
technolog
across
disciplin
may
prove
use
context
bacteri
surfac
display
improv
exist
applic
perhap
enabl
new
one
final
address
import
caveat
despit
tantal
clinic
biotechnolog
prospect
surfaceengin
bacteria
implement
outsid
laboratori
greatli
hinder
due
concern
environment
danger
genet
modifi
organ
gmo
therefor
includ
discuss
theoret
risk
present
set
recombin
techniqu
circumv
see
box
number
potenti
transform
applic
devis
surfaceengin
bacteria
practic
use
rel
limit
due
four
major
concern
potenti
hazard
releas
gmo
environ
first
risk
parallel
transfer
foreign
dna
organ
particular
issu
case
virul
gene
express
vaccin
vector
risk
minim
increas
stabil
genet
modif
chromosom
integr
foreign
dna
ensur
chromosom
insert
site
distant
especi
mobil
genet
element
transposon
second
possibl
releas
organ
signific
fit
advantag
lead
unrestrain
propag
gmo
damag
environment
consequ
fear
outcom
may
allay
use
auxotroph
strain
unabl
surviv
environ
ie
biolog
contain
organ
use
nonliv
vehicl
omv
bg
inactiv
spore
third
risk
uniqu
vaccin
deliveri
possibl
attenu
vaccin
strain
revert
virul
genotyp
thu
place
vaccine
andor
close
contact
danger
contract
diseas
attenu
usual
accomplish
disrupt
gene
involv
microand
nanoengin
cell
surfac
major
bacteri
protein
display
method
employ
common
strategi
heterolog
protein
interest
passeng
genet
fuse
endogen
surfac
protein
carrier
structur
cell
envelop
turn
determin
extracellular
chimera
resid
gramneg
organ
associ
om
figur
gramposit
bacteria
chimera
usual
attach
peptidoglycan
cell
wall
figur
either
virul
central
metabol
pathway
former
associ
greater
risk
virul
factor
gener
locat
mobiliz
genet
element
may
acquir
wildtyp
organ
metabol
gene
meanwhil
gener
locat
chromosom
attenu
site
stabl
fourth
concernintroduct
drug
resist
gene
environmenti
perhap
worrisom
laboratori
set
maintain
heterolog
gene
episom
bacteria
use
antibiot
resist
select
marker
simplest
recombin
techniqu
perfectli
accept
practic
howev
imper
genet
engin
bacteria
releas
environmentsuch
vaccin
bioremedi
devicesto
free
marker
prevent
spread
drug
resist
two
genet
method
satisfi
requir
establish
balanc
lethal
system
wide
use
recombin
effect
gramneg
gramposit
organ
balanc
lethal
approach
use
episom
plasmid
express
gene
interest
importantli
plasmid
maintain
complement
rather
antibiot
resist
gener
markerless
carrier
strain
use
balanc
lethal
system
proce
follow
key
metabol
gene
one
involv
amino
acid
synthesi
delet
render
strain
auxotroph
genet
delet
achiev
heterolog
recombin
host
chromosom
suicid
vector
encod
null
allel
resist
marker
flank
recombinas
target
site
ii
antibioticmedi
select
transform
iii
subsequ
excis
resist
marker
transient
express
recombinas
note
markerless
strain
may
identifi
use
neg
select
marker
sacb
confer
sensit
sucros
mutant
strain
transform
plasmid
contain
two
element
gene
interest
metabol
gene
delet
host
thu
episom
element
stabli
maintain
recombin
strain
loss
would
remov
complement
essenti
gene
recombin
stabil
gene
interest
guarante
direct
integr
bacteri
chromosom
achiev
use
modifi
strain
express
lambar
bacteriophag
systema
set
enzym
greatli
increas
effici
homolog
recombin
induct
recombin
enzym
strain
electropor
linear
dna
construct
contain
heterolog
gene
ii
flank
consist
sequenc
complementari
chromosom
insert
site
iii
select
marker
flank
recombinas
target
site
select
integr
marker
remov
use
recombinas
produc
desir
strain
number
recombin
techniqu
develop
express
fusion
protein
surfac
gramneg
speci
figur
peptid
small
protein
approxim
amino
acid
exogen
sequenc
may
insert
protein
compris
surfac
appendag
pili
flagella
ii
extracellular
loop
outer
membran
protein
lamb
ompa
iii
lipoprotein
virul
factor
anchor
surfac
howev
display
larger
protein
enzym
passeng
must
fuse
cterminu
carrier
rather
intracistron
figur
iii
autodisplay
one
system
commonli
use
display
larg
protein
strategi
involv
fusion
passeng
protein
autotransport
class
virul
factor
includ
proteas
neisseria
gonorrhoea
misl
salmonella
enterica
serovar
typhimurium
aidai
adhesin
involv
diffus
adher
escherichia
coli
normal
express
autotransport
insert
om
form
porinlik
structur
ctermin
domain
ntermin
domain
connect
via
long
flexibl
linker
subsequ
transloc
pore
access
extracellular
milieu
therefor
autotransport
may
hijack
allow
surfac
display
replac
nativ
ntermin
domain
heterolog
passeng
notabl
advantag
approach
later
mobil
carrier
within
om
enabl
multimer
passeng
protein
demonstr
surfacedisplay
streptavidin
nitrilas
klebsiella
pneumonia
sorbitol
dehydrogenas
major
system
express
larg
protein
bacteri
surfac
involv
fusion
ice
nucleat
protein
inp
abund
lipoprotein
present
om
mani
plant
pathogen
uniqu
properti
inp
mechan
surfac
express
rather
thread
im
unfold
state
like
major
bacteri
protein
inp
transloc
fulli
fold
thu
inpmedi
surfac
display
accommod
passeng
protein
associ
bulki
cofactor
hemeand
diflavincontain
cytochrom
enzym
sinc
introduct
autodisplay
inpbas
express
system
develop
highli
optim
wellcharacter
biotechnolog
platform
chimera
express
use
method
effici
travers
im
periplasm
reach
cell
surfac
great
abund
molecul
per
cell
case
autodisplay
ii
resid
stabli
surfac
without
substanti
detach
loss
recombin
protein
iii
resist
degrad
proteas
within
periplasm
space
iv
disrupt
integr
cell
envelop
induc
growth
defect
given
properti
along
welldefin
genet
techniqu
requir
autodisplayand
inpbas
express
surfac
display
gramneg
bacteria
consid
straightforward
robust
class
techniqu
wherea
surfac
display
gramneg
bacteria
achiev
fusion
carrier
protein
express
om
differ
strategi
must
undertaken
gramposit
organ
lack
outer
vestment
figur
common
method
involv
attach
protein
directli
surfaceexpos
peptidoglycan
cell
wall
use
class
enzym
call
sortas
figur
membraneassoci
enzym
recogn
specif
pentapeptid
sort
motif
secret
protein
cleav
within
motif
coval
attach
ntermin
portion
cell
wall
thu
fusion
passeng
protein
nterminu
sortas
substrat
protein
enabl
effici
express
gramposit
cell
surfac
sortasemedi
display
heterolog
protein
proven
especi
robust
coval
natur
attach
rigid
peptidoglycan
substrat
ensur
stabil
surfac
express
altern
sortasebas
surfac
display
explor
well
exampl
passeng
fuse
transmembran
protein
extend
plasma
membran
cell
wall
extracellular
space
effect
display
cell
surfac
figur
ii
surfac
express
also
achiev
use
chimera
passeng
protein
compris
bacteri
cell
surfac
layer
slayer
selfassembl
crystallin
lattic
coat
sever
speci
bacteria
figur
iii
notabl
absenc
om
gramposit
organ
remov
signific
obstacl
protein
transloc
facilit
display
larg
protein
use
sortasemedi
transmembran
fusion
slayer
fusion
protein
methodolog
final
somewhat
uniqu
approach
involv
fusion
autolysinscel
wall
degrad
enzym
bind
noncoval
compon
gramposit
cell
wall
figur
iv
key
advantag
methodolog
autolysinpasseng
chimera
may
express
model
organ
eg
e
coli
purifi
adsorb
cell
wall
wildtyp
gramposit
strain
thu
use
strategi
gramposit
bacteria
reengin
heterolog
surfac
protein
remain
genet
unchang
therebi
circumv
potenti
environment
risk
gmo
see
box
certain
bacteri
speci
within
clostridium
bacillu
genera
display
uniqu
behavior
known
sporul
bacteria
transform
metabol
activ
veget
cell
dormant
structur
spore
respons
nutrient
deplet
condit
process
bacteri
dna
becom
cocoon
within
multilay
wall
peptidoglycan
concentr
protein
shell
render
dna
impervi
toxic
chemic
radiat
extrem
ph
temperatur
dehydr
spore
thu
abl
surviv
inhospit
environ
extend
periodsin
one
report
million
year
despit
spore
extraordinari
inert
surfac
protein
remain
function
part
due
attach
stabl
matrix
see
section
readi
sens
nutrient
replet
germin
fulli
activ
state
numer
method
establish
display
heterolog
protein
remark
structur
involv
fusion
carrier
protein
express
spore
surfac
carrier
includ
cotb
cotc
cotg
bacillu
subtili
bcla
bclb
bacillu
anthraci
bacillu
thuringiensi
spore
reengin
mean
proven
use
biosensor
biocatalyst
vaccin
applic
spore
discuss
detail
worth
describ
uniqu
advantag
spore
offer
convent
bacteria
three
biotechnolog
set
first
similar
veget
cell
system
spore
well
suit
biosensingth
detect
report
analyt
solut
see
section
sensit
low
cost
eas
use
small
size
except
stabil
spore
howev
allow
use
outsid
laboratori
harsh
natur
environ
convent
cellular
system
surviv
second
spore
uniqu
protein
need
travers
membran
order
express
cell
surfac
instead
protein
attach
outermost
layer
spore
assembl
within
cytoplasm
mother
cell
sporul
properti
allow
express
multim
streptavidin
protein
problemat
hydrophob
domain
preclud
membran
transloc
enzym
requir
cofactor
larg
protein
final
spore
abil
germin
confer
advantag
context
vaccin
deliveri
remain
stabl
storag
room
temperatur
transform
deliv
nutrientrich
environ
tissu
veget
cell
potent
immunostimulatori
properti
see
section
outer
membran
vesicl
omv
bacteri
ghost
bg
acellular
deriv
gramneg
envelop
contain
parent
cell
surfaceexpress
protein
omv
consist
outer
membranederiv
bilamellar
vesicl
nm
diamet
continu
elabor
grow
gramneg
bacteria
effici
surfac
display
omv
achiev
fuse
passeng
protein
e
coli
toxin
clya
becom
concentr
structur
vesicul
omv
particular
util
vaccin
deliveri
vehicl
stabl
prolong
storag
strongli
immunogen
virtu
mani
immunostimulatori
compon
om
vesicl
retain
present
environment
safeti
hazard
intact
cell
unabl
propag
see
fusion
two
membran
protein
e
oligomer
lead
format
lysi
tunnel
figur
cytoplasm
releas
extracellularli
howev
due
control
natur
lytic
event
effect
seal
im
om
cell
envelop
morpholog
periplasm
content
maintain
commonli
anchor
foreign
protein
bg
achiev
fusion
passeng
outer
membran
protein
ompa
final
like
omv
bg
excel
vehicl
vaccin
deliveri
potent
immunostimulatori
properti
inabl
replic
bacteri
surfac
display
lent
host
biotechnolog
biomed
applic
organ
four
categori
display
antigen
vaccin
design
ii
express
antitumor
protein
cancer
therapi
iii
immobil
enzym
biocatalysi
iv
set
relat
applic
involv
bind
surfac
protein
molecul
solut
biosens
biosorpt
librari
screen
topic
discuss
brief
pleas
see
focus
review
greater
detail
gener
vaccin
two
compon
pathogenassoci
antigen
serv
target
adapt
immun
respons
adjuvanta
materi
potenti
tune
immun
respons
codeliv
antigen
uptak
compon
antigen
present
cell
apc
dendrit
cell
repres
crucial
initi
step
gener
immun
respons
protect
futur
infect
surfaceengin
bacteri
vaccin
construct
express
pathogenassoci
antigen
inactiv
bacterium
liveattenu
pathogen
food
grade
nonpathogen
bacteri
speci
bacteri
vector
abl
serv
adjuv
due
numer
immunostimulatori
pathogenassoci
molecular
pattern
pamp
present
within
cytoplasm
cell
envelop
includ
bacteri
dna
peptidoglycan
gramposit
lipoprotein
gramneg
lipopolysaccharid
lp
set
pamp
associ
viabl
cell
vitapamp
includ
mrna
cyclic
dinucleotid
local
antigen
bacteri
surfac
per
se
appear
import
immunogen
recombin
vaccin
vector
almost
direct
comparison
surfac
cytoplasm
secret
express
system
surfaceengin
vaccin
proven
efficaci
even
normal
magnitud
express
one
reason
improv
immunogen
surfaceanchor
antigen
effici
codeliv
adjuv
bacteri
pamp
apc
essenti
gener
effect
immun
respons
furthermor
surfac
express
produc
multival
display
antigen
cell
surfac
known
promot
crosslink
bcell
receptor
stimul
humor
immun
respons
bacteri
surfac
display
especi
use
develop
mucos
vaccin
sever
advanc
far
clinic
trial
tabl
provid
summari
bacteri
vector
use
mucos
vaccinolog
catalog
pathogen
vaccin
target
sever
argument
propos
surfaceengin
bacteria
proven
effect
mucos
immunogen
first
deriv
simpli
size
bacteri
vector
nm
diamet
consid
particul
deliveri
antigen
particul
vehicl
known
greatli
improv
antigen
present
apc
lead
stronger
elicit
immun
respons
mucosa
antigen
solubl
form
second
intrins
adjuvant
bacteria
provid
potent
immunostimulatori
signal
overcom
bia
toward
toler
exist
mucos
immun
tissu
third
transient
colon
andor
mild
infect
induc
live
bacteri
vaccin
lead
sustain
local
gener
antigen
mucosa
greatli
improv
deliveri
apc
final
bacteri
vaccin
uniqu
effici
gain
access
apc
within
mucos
immun
tissu
virtu
surfac
properti
prevent
trap
within
mucu
layer
surfac
adhes
protein
carbohydr
promot
attach
mucos
epithelium
transloc
immun
induct
site
respect
bacteri
surfac
display
worth
note
surfac
express
target
protein
antibodi
bind
protein
epitheli
cell
shown
increas
adhes
transloc
bacteri
vaccin
vector
immun
tissu
use
live
bacteria
cancer
therapi
fascin
research
sinc
earli
nineteenth
centuri
tumor
regress
observ
set
cancer
patient
contract
ga
gangren
aggress
soft
tissu
infect
caus
c
perfringen
anticanc
effect
bacteria
sinc
trace
number
intrins
properti
organ
abil
home
tumor
tissu
select
healthi
tissu
case
c
perfringen
abil
aris
fact
spore
select
germin
within
core
solid
tumor
hypox
due
poor
vascular
facult
anaerob
like
salmonella
speci
l
monocytogen
meanwhil
accumul
cancer
tissu
due
entrap
tortuou
tumor
vasculatur
chemotaxi
toward
nutrient
releas
die
cancer
cell
preferenti
growth
tumor
uniqu
metabol
milieu
also
protect
attack
white
blood
cell
due
local
immunosuppress
upon
accumul
tumor
bacteria
promot
cell
death
compet
nutrient
stimul
normal
suppress
intratumor
immun
cell
attack
cancer
cell
advent
genom
recombin
technolog
antitumor
bacteriawhich
larg
remain
curios
field
cancer
treatmenthav
transform
fine
tune
therapeut
devic
surfac
express
protein
antitumor
properti
instanc
invasin
adhes
protein
pseudotuberculosi
mediat
entri
bacterium
nonphagocyt
mammalian
cell
express
surfac
nonpathogen
e
colibas
therapeut
strain
promot
invas
cancer
cell
strategi
util
deliv
transkingdom
rnai
mous
model
colon
cancer
silenc
express
epitheli
oncoprotein
anoth
exampl
enterica
serovar
typhimurium
engin
express
apoptosispromot
protein
fa
ligand
cell
surfac
modifi
bacterium
shown
inhibit
growth
primari
breast
colon
cancer
well
pulmonari
metastas
mice
final
bacteria
engin
express
cytotox
prokaryot
protein
cytolysin
surfaceloc
poreform
toxin
produc
strain
significantli
inhibit
tumor
growth
metastasi
murin
model
colon
lung
cancer
number
nonsurfac
relat
genet
modif
shown
potenti
anticanc
effect
bacteri
vector
well
mani
could
conceiv
combin
surfac
display
creat
effect
multimod
therapeut
instanc
salmonella
spp
design
secret
proinflammatori
cytokin
promot
adapt
immun
respons
well
cytotox
agent
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
directli
induc
tumor
lysi
second
effect
modif
express
genet
circuit
select
activ
gene
express
respons
cue
tumor
microenviron
circuit
use
coupl
cytotoxin
product
arriv
tumor
reduc
offtarget
toxic
tissuedamag
protein
third
express
prodrug
convert
enzym
tumorloc
bacteria
use
activ
chemotherapeut
prodrug
situ
increas
drug
concentr
poorli
access
tumor
core
reduc
collater
damag
healthi
tissu
efficaci
approach
confirm
murin
model
also
patient
well
phase
trial
shown
attenu
salmonella
strain
express
e
coli
cytosin
deaminas
genewhich
convert
prodrug
activ
chemotherapeut
home
tumor
gener
significantli
elev
intratumor
level
respect
serum
cours
intraven
administr
live
bacteria
without
risk
side
effect
instanc
preliminari
toler
studi
show
dosedepend
elicit
cytokin
associ
hypotens
fever
thrombocytopenia
anemia
diarrhea
nausea
vomit
howev
detoxif
proinflammatori
bacteri
compon
lp
see
section
attenu
mutat
virul
factor
gene
central
metabol
pathway
see
box
titrat
toler
dose
care
clinic
monitor
postadministr
immunotox
live
bacteria
may
minim
allow
potenti
valuabl
therapeut
test
clinic
set
addit
serv
devic
design
directli
kill
cancer
cell
genet
engin
bacteria
also
proven
highli
effect
platform
develop
anticanc
vaccin
actual
two
approach
overlap
mani
way
exampl
vaccin
vector
l
monocytogen
colon
tumor
induc
direct
cytotox
convers
oncotherapeut
bacteria
lead
tumor
damag
also
tumorspecif
adapt
respons
due
releas
cancer
cell
antigen
bacteri
induc
lysi
nevertheless
cancer
vaccinolog
elicit
immun
respons
primari
object
ultim
goal
immunemedi
clearanc
primari
tumor
metastas
well
context
immunostimulatori
properti
live
bacteri
vector
leverag
break
inher
toler
cancerassoci
antigen
exist
similar
self
protein
resid
immunosuppress
tumor
milieu
notabl
translat
bacteriabas
anticanc
vaccin
clinic
recent
begun
phase
trial
demonstr
safeti
promis
listeri
vaccin
cervic
carcinoma
bacteri
surfac
display
use
design
anticanc
vaccin
extens
mean
antigen
express
instanc
tcell
epitop
commonli
express
tumor
antigen
insert
fimbrial
protein
enterica
serovar
typhimurium
creat
vaccin
capabl
gener
robust
antigenspecif
tcell
respons
mice
similarli
oncoprotein
involv
develop
cervic
cancer
kda
oncofetoprotein
found
mani
human
cancer
surfac
express
lactic
acid
bacteria
gener
effect
mucos
vaccin
human
papillomavirusinduc
tumor
shown
mous
model
cervic
cancer
immunogen
live
bacteri
vaccin
greatli
potenti
vector
simultan
secret
proinflammatori
cytokin
import
find
illustr
potenti
combin
multipl
recombin
modif
therapeut
also
suggest
vaccinegener
cytokin
secret
strategi
could
principl
boost
immunogen
live
vaccin
addit
antigen
express
bacteri
surfac
display
use
improv
target
bacteri
vector
tumor
analog
manner
target
vaccin
mucos
immun
tissu
describ
section
attenu
salmonella
vaccin
strain
exampl
surfac
display
singl
chain
antibodi
fragment
specif
carcinoembryon
antigena
glycoprotein
overexpress
mani
epithelialderiv
cancerswa
found
significantli
improv
intratumor
accumul
recombin
bacteria
vivo
use
microbi
express
enzym
bio
catalysi
chemic
reaction
long
histori
includ
ancient
practic
bread
chees
make
beer
wine
ferment
recent
antibiot
product
valu
enzym
chemic
synthesi
lie
potenti
catalyz
reaction
remark
rapid
highli
chemo
regio
enantioselect
manner
mild
condit
minim
toxic
wast
gener
protect
deprotect
step
energi
expenditur
involv
convent
synthet
chemistri
furthermor
direct
evolut
protein
engin
techniqu
describ
section
modifi
enzym
may
design
remain
stabl
elev
temperatur
solut
organ
solvent
ii
accept
nonn
substrat
iii
catalyz
novel
reaction
properti
led
rapidli
grow
interest
use
biocatalyst
industri
product
deterg
food
cosmet
textil
fine
chemic
biofuel
pharmaceut
fact
commerci
product
produc
use
enzym
gener
industri
enzym
market
valu
us
billion
immobil
enzym
bacteri
cell
surfac
offer
key
advantag
use
free
enzym
biocatalysi
first
attach
enzym
solid
matrix
bacteri
envelop
vastli
increas
stabil
one
exampl
surfaceexpress
organophosphoru
hydrolas
retain
catalyt
effici
astound
day
cultur
second
product
enzym
cell
surfac
obviat
need
protein
purif
labori
costli
third
genet
engin
biocatalyst
strain
complet
access
nearli
infinit
suppli
enzym
requir
cultur
inexpens
growth
mediumagain
greatli
reduc
price
product
enzym
display
cell
surfac
also
advantag
cytoplasm
express
allow
use
substrat
gener
product
imperm
lipid
membran
wide
array
enzym
express
surfac
bacteria
includ
oxidoreductas
eg
cytochrom
enzym
variou
hydrolas
eg
glycosyltransferas
phosphatas
lipas
esteras
organ
reengin
enzym
use
degrad
organ
pollut
gener
fuel
renew
energi
sourc
eg
plant
biomass
manufactur
chemic
compound
pharmaceut
industri
purpos
section
discuss
applic
bacteri
surfac
display
base
bind
surfacebound
protein
molecul
solut
may
protein
small
molecul
element
myriad
invent
use
bind
interact
establish
fall
head
biosens
biosorpt
screen
figur
last
two
decad
research
endeavor
genet
engin
bacteria
serv
devic
detect
quantifi
molecul
solut
end
entir
class
twocompon
biosensor
figur
devis
bacteria
express
genet
sensor
bind
analyt
transduc
bind
event
dosedepend
chang
activ
promot
ii
report
gene
driven
said
promot
produc
measur
signal
eg
luciferas
green
fluoresc
protein
one
notabl
exampl
e
coli
convert
biosensor
arsenitecontain
compound
transform
plasmid
contain
ar
operon
mediat
bacteri
resist
toxin
regulatori
circuit
work
follow
absenc
arsenit
protein
arsr
repress
ar
promot
upon
bind
metalloid
unbind
promot
permit
express
sever
gene
detoxifi
extrud
arsenitecontain
compound
thu
express
promoterless
bacteri
luciferas
luxab
gene
downstream
ar
promot
e
coli
simpl
biolog
sensor
arsenit
could
construct
remark
due
sensit
arsr
substrat
signal
amplif
inher
operon
reengin
bacteri
strain
capabl
detect
arsenit
subattomolar
time
detect
limit
convent
techniqu
similarli
design
biosensor
use
measur
concentr
variou
heavi
metal
organ
toxin
set
environment
monitor
ii
nutrient
studi
soil
microb
metabol
iii
analyt
potenti
clinic
relev
quorumsens
molecul
antimicrobi
drug
date
twocompon
biosensor
construct
intracellular
sens
mechan
howev
surfaceengin
bacteria
use
basi
novel
elisalik
quantit
immunoassay
approach
singl
chain
variabl
fragment
scfv
antibodi
protein
express
surfac
bacteria
analog
immobil
antibodi
elisa
plate
sampl
incub
recombin
bacteria
antibodybound
analyt
separ
unbound
analyt
via
centrifug
quantif
bound
analyt
perform
use
horseradish
antibodi
conjug
detect
mechan
along
line
chen
et
al
construct
scfvexpress
bacteria
capabl
measur
concentr
cardiac
glycosid
drug
digoxin
nanomolar
rang
success
approach
indic
entic
possibl
diagnost
devic
may
complement
even
replac
tradit
immunoassay
like
elisa
due
cost
effici
abil
selfregener
rel
high
sensit
bacteria
express
peptid
protein
ligand
solubl
bind
partner
use
effect
chromatograph
media
purif
rang
molecul
figur
exampl
biosorpt
heavi
metal
toxin
metalbind
peptid
surfac
e
coli
staphylococcu
speci
use
environment
remedi
pollut
water
meanwhil
express
peptid
epitop
enabl
isol
singl
antibodi
clone
polyclon
serum
sampl
produc
immun
rabbit
approach
may
serv
altern
hybridoma
develop
access
monoclon
antibodi
scope
technolog
fact
like
broaden
light
recent
landmark
studi
protein
engin
show
novel
protein
capabl
bind
ligand
interest
ration
design
silico
author
studi
describ
gener
comput
method
design
small
moleculebind
site
appli
creat
protein
capabl
bind
steroid
digoxigenin
standard
direct
evolut
methodolog
describ
section
group
abl
obtain
optim
binder
picomolar
affin
exquisit
select
digoxigenin
relat
steroid
digitoxigenin
progesteron
abil
program
ligand
specif
synthet
protein
theori
possibl
design
biosensor
biosorb
virtual
small
moleculea
truli
revolutionari
advanc
similar
commonli
use
phage
display
techniqu
bacteri
surfac
display
enabl
identif
protein
peptid
desir
bind
attribut
link
ident
display
protein
genet
sequenc
achiev
larg
set
heterogen
bacteri
clone
gener
transform
bacteria
surfac
display
vector
librari
contain
either
cdna
randomli
mutat
sequenc
subject
iter
round
screen
amplif
sequenc
identifi
surfac
protein
respons
mediat
bind
interact
figur
use
bacteria
rather
phage
screen
advantag
densiti
surfac
protein
express
per
cell
dwarf
molecul
display
per
phage
greatli
enhanc
sensit
screen
addit
advantag
bacteria
contrast
phage
replic
autonom
suffici
size
detect
fluorescenceactiv
cell
sort
fac
instrument
allow
quantit
fluoresc
individu
cell
rate
upward
per
second
technolog
enabl
highli
effici
identif
peptid
protein
desir
properti
instanc
surfac
display
peptid
librari
linear
epitop
antibodi
rapidli
determin
incub
fluoresc
label
antibodi
individu
clone
facsmedi
select
antibodybound
bacteria
figur
similar
approach
taken
discov
peptid
rang
target
includ
tumor
cell
human
signal
protein
neural
stem
cell
viral
protein
etc
addit
novel
inhibitor
enzym
cathepsin
g
trypsin
cull
surfacedisplay
peptid
librari
base
inhibitor
enzym
bind
affin
one
particularli
power
applic
combinatori
bacteri
display
direct
evolut
process
protein
subject
round
random
mutagenesi
screen
often
fac
sort
identifi
evolv
protein
improv
uniqu
function
use
bacteria
essenti
direct
evolut
experi
short
gener
time
amen
genet
manipul
compat
sort
instrument
surfac
displaybas
direct
evolut
found
sever
applic
thu
far
one
exampl
antibodi
improv
affin
gener
anchor
periplasm
express
apex
antibodi
librari
e
coli
permeabil
om
incub
fluoresc
antigen
fac
sort
label
cell
enzym
novel
activ
also
evolv
use
bacteri
surfac
display
importantli
identif
hit
screen
differ
previous
describ
method
clone
identifi
interact
fluoresc
bind
partner
attach
fluoresc
reaction
product
cell
surfac
instanc
develop
endopeptidas
novel
substrat
specif
librari
bacteri
clone
display
enzym
variant
incub
peptid
substrat
contain
bodipi
fluorophor
one
side
scissil
bond
quencher
clone
express
enzym
capabl
cleav
bond
would
electrostat
captur
unquench
bodipycontain
cleavag
product
membran
virtu
product
overal
charg
allow
rapid
detect
isol
fac
describ
surfac
display
exogen
protein
accomplish
fusion
passeng
extracellular
carrier
heterolog
express
glycan
meanwhil
challeng
biosynthesi
templat
direct
thu
instal
nonn
sugar
bacteri
cell
surfac
must
achiev
indirectli
via
recombin
express
enzym
mediat
synthesi
attach
remodel
oligosaccharid
delet
endogen
gene
involv
process
see
box
detail
descript
endogen
bacteri
glycan
three
basic
strategi
use
bacteri
glycoengin
first
operon
encod
entir
metabol
pathway
respons
synthesi
given
sugar
clone
transfer
carrier
strain
figur
approach
use
express
pseudomona
aeruginosa
capsular
polysaccharid
shigella
lp
number
heterolog
speci
second
strategi
involv
sitespecif
nlink
glycosyl
target
protein
figur
accomplish
express
gene
requir
biosynthesi
nonn
sugar
ii
pglb
oligosaccharyltransferas
clone
campylobact
jejuni
catalyz
surfac
glycom
gramposit
organ
consist
glycoprotein
slayer
protein
secondari
cell
wall
polysaccharid
link
slayer
peptidoglycan
teichoic
acid
anion
glycopolym
thread
cell
wall
capsular
polysaccharid
speci
express
capsul
biosynthesi
capsul
repres
one
major
target
glycoengin
take
place
cytoplasm
nucleotid
phosphosugar
assembl
massiv
polym
speciesspecif
oligosaccharid
repeat
unit
membraneassoci
enzym
transloc
cell
surfac
dedic
transport
pathway
capsular
polysaccharid
shield
bacteria
immun
system
prevent
opson
antibodi
complement
consequ
reduc
phagocytosi
host
immun
cell
gramneg
bacteria
also
possess
glycoprotein
pili
well
capsular
polysaccharid
mani
speci
uniqu
express
complex
glycolipid
lpsanoth
favorit
target
glycoengin
figur
lp
also
refer
endotoxin
abil
induc
toxic
shock
mammal
constitut
om
gramneg
bacteria
three
basic
structur
compon
figur
lipid
highli
conserv
across
genera
mediat
endotox
repres
hydrophob
moieti
anchor
lp
membran
attach
glycan
asparagin
residu
within
glycosyl
sequon
deynxst
iii
modifi
surfac
protein
contain
heptapeptid
glycosyl
sequon
third
strategi
entail
glycan
remodel
addit
andor
delet
enzym
modifi
cell
surfac
oligosaccharidesmost
commonli
lp
describ
follow
section
figur
express
heterolog
surfac
sugar
glycoengin
method
found
number
use
applicationsth
success
perhap
vaccin
design
one
effect
vaccin
platform
involv
heterolog
express
carbohydr
antigen
glycoprotein
capsular
polysaccharid
lp
surfac
attenu
vaccin
strain
analog
recombin
proteinexpress
vaccin
describ
bacteri
vector
serv
potent
adjuv
stimul
adapt
immun
respons
pathogenassoci
glycoantigen
second
major
approach
involv
attenu
pathogen
genet
modif
lp
allow
direct
vaccin
avirul
pathogen
strain
common
molecular
alter
lp
diagram
produc
hexaacetyl
lipid
express
acyltransferas
lpxl
lpxm
contrast
immunoevas
nativ
glycoform
reengin
lp
variant
potent
activ
tolllik
receptor
lead
elicit
proinflammatori
immun
respons
mediat
rapid
clearanc
bacteria
gener
adapt
immun
bacteri
vector
method
appli
construct
attenu
vaccin
shigella
flexneri
pesti
salmonella
spp
francisella
tularensi
leptospira
interrogan
neisseria
meningitid
moraxella
catarrhali
k
pneumonia
surfac
glycoengin
also
use
develop
potenti
revolutionari
class
antiinfect
probiot
avirul
bacteri
strain
express
oligosaccharid
receptor
bacteri
exotoxin
caus
cholera
shigellosi
travel
diarrhea
togeth
claim
hundr
thousand
live
per
year
worldwid
rational
approach
exotoxin
sequest
receptor
decoy
probiot
strain
gut
lumen
rather
bind
target
colon
epitheli
cell
induc
diarrheal
diseas
due
densiti
multival
receptor
express
surfac
probiot
strain
exotoxin
intercept
vivo
extraordinari
effici
one
studi
mg
recombin
bacteria
shown
neutral
shiga
toxin
potent
exotoxin
releas
shigella
spp
lead
dysenteri
mice
twice
daili
administr
therapeut
strain
provid
protect
otherwis
fatal
shigellosi
even
kill
form
thu
addit
cost
effect
given
largescal
product
achiev
simpl
ferment
therapeut
approach
highli
effect
safe
furthermor
reengin
probiot
appli
select
pressur
evolut
resist
pathogen
strain
specif
intercept
diseasecaus
toxin
rather
kill
pathogen
recent
similar
principl
guid
develop
probiot
express
glycan
receptor
adhes
protein
uropathogen
strain
e
coli
prophylact
treatment
recombin
strain
abrog
bind
pathogen
urinari
epithelium
prevent
develop
urinari
tract
infect
mice
unfortun
despit
great
promis
glycoengin
probiot
hold
treatment
infecti
diseas
slow
clinic
develop
due
apprehens
surround
releas
gmo
see
box
final
applic
glycoengin
relat
product
recombin
glycoprotein
import
process
highlight
fact
approxim
therapeut
relev
protein
saccharid
modif
includ
catabol
enzym
use
treat
inborn
error
metabol
erythropoietin
use
treatment
chronic
kidney
diseas
carbohydr
moieti
affect
sever
pharmacolog
properti
glycoprotein
includ
vivo
activ
halflif
proteolyt
stabil
tissu
target
glycoprotein
also
use
vaccin
fact
commonli
use
vaccinesinclud
h
influenza
n
meningitidi
pneumoniaeconsist
capsular
conjug
convent
method
produc
compound
involv
isol
polysaccharid
capsul
pathogen
purif
recombin
carrier
protein
chemic
coupl
polysaccharid
carrier
protein
purif
glycoconjugatesa
typic
low
yield
expens
process
altern
research
pursu
total
synthesi
glycan
despit
led
strategi
present
chapter
express
heterolog
protein
sugar
bacteri
cell
surfac
proven
use
myriad
applic
nevertheless
fall
short
one
import
regard
offer
way
instal
nongenet
encod
molecul
fluorophor
affin
tag
cytotox
drug
bacteria
compound
altern
set
approach
pioneer
chemic
biologist
last
decad
must
employ
gener
two
basic
strategi
instal
small
molecul
onto
bacteri
surfac
direct
twostep
label
direct
label
small
conjug
incub
activ
grow
cell
cell
take
conjug
incorpor
via
endogen
biosynthet
pathway
polymer
structur
cell
surfac
protein
sugar
contrast
twostep
label
involv
incorpor
monom
equip
small
reactiv
chemic
handl
azid
cell
surfac
structur
ii
subsequ
bioorthogon
ligat
small
molecul
function
complementari
reactiv
group
alkyn
exampl
surfaceexpos
handl
twostep
approach
particularli
use
instal
larg
compound
unabl
pass
plasma
membran
bulki
allow
direct
incorpor
enzym
involv
polym
biosynthesi
besid
azidetermin
alkyn
click
reaction
pair
commonli
use
bioorthogon
reaction
pair
includ
azid
phosphin
stauding
ligat
aldehydesketon
hydrazin
hydroxylamin
tetrazin
strain
alken
transcycloocten
twostep
metabol
label
glycan
initi
develop
bertozzi
et
al
repres
paradigmat
exampl
chemic
surfac
engin
methodolog
monosaccharid
modifi
chemic
handl
first
assimil
surfaceassoci
sugar
small
molecul
interest
attach
function
glycan
cell
surfac
outer
membran
glycolipid
lp
serv
common
target
modif
although
recent
studi
shown
glycoprotein
amen
chemic
manipul
well
polypeptid
cell
surfac
similarli
reengin
via
twostep
metabol
label
techniqu
analog
function
monosaccharid
use
label
glycan
chemic
tag
noncanon
amino
acid
ncaa
incorpor
protein
present
cell
surfac
subsequ
ligat
end
ncaa
azidohomoalanin
azidonorvalin
azidonorleucin
shown
serv
methionin
surrog
replac
endogen
amino
acid
translat
alkynefunction
compound
turn
attach
proteinbound
surfaceexpos
azid
approach
methionin
global
replac
ncaasa
particularli
valuabl
featur
certain
set
eg
proteom
analysi
howev
sitespecif
modif
altern
techniquepion
schultz
et
almust
use
first
genet
engin
synthetas
pair
design
incorpor
ketonecontain
eleg
chemic
develop
approach
hamper
extrem
chemic
complex
oligosaccharid
deriv
stereoisomer
divers
monosaccharid
subunit
numer
possibl
glycosid
linkag
frequent
branch
heterolog
express
nlink
glycosyl
system
e
coli
meanwhil
allow
scalabl
inexpens
product
easili
purifi
homogen
glycoconjug
sitespecif
instal
glycan
target
protein
still
need
improv
identif
bacteri
oligosaccharyltransferas
attach
glycan
nonreduc
sugar
acceptor
protein
bacteri
glycotag
technolog
potenti
revolution
product
therapeut
immunomodulatori
glycoprotein
futur
owe
selfregener
natur
bacteri
vector
immunogen
properti
strong
linkag
amen
genet
manipul
bacteri
surfac
display
proven
extraordinarili
versatil
econom
biotechnolog
system
applic
strategi
vaccinolog
led
agent
clinic
trial
catalyt
biofactori
play
key
role
industri
pharmaceut
synthesi
bacteriabas
screen
technolog
driven
forward
basic
research
howev
believ
surfac
engin
paradigm
may
improv
combin
heterolog
express
protein
saccharid
mani
complementari
technolog
elucid
includ
comput
protein
engin
even
genet
surfac
display
benefit
integr
excit
set
method
emerg
chemic
biolog
allow
instal
synthet
compound
cell
surfac
see
box
togeth
power
techniqu
would
impart
incred
versatil
surfac
engin
platform
transform
cell
envelop
verit
tabula
rasa
abl
accommod
manner
protein
sugar
synthet
chemic
virtual
combin
tool
instanc
one
may
imagin
construct
anticanc
therapeut
strain
express
tumor
antigen
trigger
adapt
immun
respons
ii
oligosaccharid
target
moieti
promot
uptak
apc
effici
antigen
present
eg
dcsign
ligand
sialyllewi
x
iii
chemotherapeut
payload
releas
upon
arriv
tumor
microenviron
thu
interdisciplinari
effort
involv
synthet
chemist
bacteriologist
biomed
engin
imagin
develop
new
class
synthet
organ
chemic
genet
reengin
bacteria
serv
novel
multimod
therapeut
biotechnolog
devic
tool
advanc
fundament
research
deepli
appreci
contribut
dr
thihan
padukkavidana
toward
complet
manuscript
ncaa
macetyllphenylalanin
recombin
surfac
protein
respons
amber
nonsens
stop
codon
introduc
bacteri
strain
strain
incub
macetyllphenylalanin
ncaa
select
incorpor
recombin
protein
final
surfaceexpos
keton
function
use
attach
point
small
molecul
contain
hydrazin
hydroxylamin
group
